FDA advances peptide push to White House
Summary
The U.S. Food and Drug Administration (FDA) sent a new policy proposal to the White House. This policy would let compounding pharmacies temporarily make and sell certain peptides that were previously limited.Key Facts
- The FDA submitted an "interim access policy" regarding peptides to the White House this week.
- The policy involves allowing compounding pharmacies to produce and sell peptides temporarily.
- Peptides are short chains of amino acids used in some medical treatments.
- This change would ease previous restrictions on peptide availability.
- The move was reported in a government filing.
- The proposal is part of healthcare discussions involving the White House.
- The Coalition to Strengthen America’s Healthcare is connected to this news.
- RFK Jr. is mentioned as advancing the peptide push, indicating involvement in the issue.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
